What Lonza Biologics?
Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. We focus on enabling treatments that prevent illness and support healthier lifestyles. We optimize scientific innovation and manufacturing technology to enable our customers to serve their patients and consumers.
What products does Lonzo make?
As of 2020, Lonza’s business areas include:
- Small Molecules: active pharmaceutical ingredients, drug product formulation.
- Biologics: mammalian, microbial, licensing, bioconjugates, parenteral drug product services, mRNA.
- Cell & Gene: cell and gene technologies, personalized medicine, bioscience.
Who bought Lonza?
Bain Capital and Cinven have struck a deal to buy Lonza’s specialty chemical business for $4.7 billion.
Is Lonza a Cdmo?
CDMO giant Lonza debuts world’s biggest gene and cell therapy manufacturing plant. Swiss CDMO giant Lonza opened what it touts as the world’s biggest manufacturing plant for producing customized viruses for use in cell and gene therapies targeting rare genetic disorders or life-threatening diseases.
How much does the CEO of Lonza make?
As the Chairman of the Board and Member of the Executive Board of Lonza AG, the total compensation of Albert Baehny at Lonza AG is $626,888.
Who are Lonza competitors?
Lonza’s competitors Lonza’s top competitors include Tokuyama, Nissan Chemical, Novozymes, WuXi Biologics, DuPont, Bristol-Myers Squibb, Catalent, Royal DSM and Divis Laboratories.
What is Lonza specialty ingredients?
Lonza’s Specialty Ingredients business operates across 17 manufacturing sites globally and has approximately 2,800 permanent employees. The business is a leading provider of microbial control solutions for Professional Hygiene and Personal Care products.
Who will buy Lonza specialty ingredients?
Bain Capital and Cinven
Bain Capital and Cinven have agreed to acquire Lonza Specialty Ingredients (LSI), a division of Lonza, in a deal worth $4.7bn. The transaction is expected to close in the second half of 2021, subject to customary closing conditions.
When did Lonza go public?
21 October 2011
Lonza Group Lp (SIX stock code: LONN VX; SGX-ST stock code: O6Z) makes its trading debut on the Main Board of the Singapore Exchange Securities Trading Limited (“SGX-ST”) on 21 October 2011 and consequently is the first SIX Swiss-listed company to dual list in Singapore.
What does Cdmo stand for in pharma?
contract development and manufacturing company
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
Does Lonza have a pension plan?
EMPLOYEES’ RETIREMENT PLAN OF LONZA INC. is a DEFINED BENEFIT PLAN. This type of plan generally provides participants with a monthly retirement benefit upon reaching a specific age and may be adjusted for early retirement.
What drugs make Lonza?
Allogeneic Cell Therapy
- Allogeneic Cell Therapy.
- iPSC Manufacturing.
- Cell Based Immunotherapies.
- Autologous Cell Therapy.
- Cell Based Immunotherapies.
- Viral Vectors.
- Services.
- Process Development.
What is Glydant™ plus liquid?
Glydant™ Plus™ Liquid – DeWolf Chemical an Azelis Company Glydant™ Plus™ Liquid is a synergistic preservation system and is is compatible with virtually all raw materials used in personal care formulations.
What is DeWolf Chem Glydant plus™?
Please visit our sister company at Dewolf Chem Glydant Plus™ is a unique and cost effective preservative featuring a high level of antimicrobial activity in a wide variety of cosmetic and personal care formulations.
What is the difference between DMDM hydantoin and Glydant plus™ liquid?
This preservative combines DMDM Hydantoin and Iodopropynyl Butylcarbamate (IPBC) that allows for a dual mode of action, offering broad spectrum efficacy. This product contains twice the amount of active ingredient as Glydant Plus™ Liquid but is offered as a powder form.
https://www.youtube.com/watch?v=UqdRmdbBLMs